Embryonal vaccine against Newcastle disease
AssigneeRegents of the University of Minnesota
InventorsJamil Ahmad, Jagdev M. Sharma
Life of this patent
Estimating the term…
Abstract
Embryonal vaccination of fowl against Newcastle disease is accomplished with ethyl methane sulfonate modified NDV-B1 virus.
Claims5
A vaccine composition against Newcastle fowl disease comprising a modified live virus strain NDV-B1-EMS deposited Jul. 14, 1992 with the American Type Culture Collection, reference number VR2378 and a pharmaceutically acceptable diluent.
A process for vaccinating fowl embryos against Newcastle disease virus comprising the step of inoculating avian embryonated eggs with an injection of at least 3 ELD.sub.50 /ml ethyl methane sulfonate-modified NDV-B1 virus.
A vaccine against Newcastle disease comprising NDV-B1 virus modified by treatment with ethyl methane sulfonate and having a MPD.sub.50 within the range of from about 10 to about 18 ELD.sub.50 /ml.
In an inactivated vaccine ready for use against symptoms in poultry by Newcastle disease virus (ndv), characterized in that the vaccine contains an ethyl methane sulfonate inactivated Newcastle disease virus derived from NDV-B1 virus, the unmodified virus being deposited under the ATCC reference number NDV-B1, VR 108, lot 11D, said vaccine containing liquid having a titre of over about 2 ELD.sub.50 /ml.
Dependencies are inferred from the claim text.